Cardiology Research and Practice / 2020 / Article / Fig 4

Research Article

Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway

Figure 4

The quantification analysis of Tie2, Akt, and eNOS phosphorylation in patients’ EPCs treated with different concentrations of aliskiren. Quantification analysis of Tie2 (a), Akt (b), and eNOS (c) phosphorylation in patients’ EPCs treated with 1 μmol/L, 10 μmol/L, or 50 μmol/L aliskiren for 12 h ( vs. non-aliskiren-treated EPCs from normotensive subjects, n = 18; vs. non-aliskiren-treated EPCs from hypertensive patients, n = 18).
(a)
(b)
(c)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.